Co-Founder & Chief Executive Officer, Mantra Bio
Alex is an entrepreneur with over a decade’s experience in building life science businesses. Alex was on the founding team and Head of Commercialization at CellASIC (acquired by Merck KgAA). He has held senior sales, product, and business strategy positions at multiple life science companies. Mantra Bio is a biotechnology company focused on developing effective and safe exosome-based therapeutics to combat intractable diseases. Mantra Bio is the creator of REVEAL, the world’s first exosome intelligence platform leveraging lab automation and deep data networks for drug discovery. Mantra Bio is a graduate of the Illumina Accelerator and currently resides at the Bayer Co-Laborator.
Illumina Accelerator Showcase: Mantra Bio
Mantra Bio is a biotechnology company focused on developing effective and safe exosome-based therapeutics for targeted drug delivery.
Engineering Exosomes For Ultra-Targeted Drug Delivery
Mantra Bio is the creator of REVEAL, the world’s first OMICS-based exosome intelligence platform. Using REVEAL, exosomes subpopulations are rapidly isolated and characterized to discover novel exosome constructs that can be directed towards specific cell targets and loaded with novel therapies.